# A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

> **NCT00590720** · PHASE2 · TERMINATED · sponsor: **MedImmune LLC** · enrollment: 11 (actual)

## Conditions studied

- Asthma

## Interventions

- **BIOLOGICAL:** MEDI528 50 mg
- **OTHER:** PLACEBO

## Key facts

- **NCT ID:** NCT00590720
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2008-12
- **Final completion:** 2009-10
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study is replaced by MI-CP198 per CPM.
- **Last updated:** 2014-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00590720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00590720, "A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00590720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*